We prepared a full earnings preview for Biogen Idec (NASDAQ: BIIB) over at 24/7 Wall St. The company responsible for Tysabri reports earnings on Friday morning. Our main question here with so many larger drug and biotech players looking to do deals is whether or not Biogen Idec can land itself a buyer…. or if it will decide to go do a deal of its own.
Other companies noted are Pfizer (NYSE: PFE), Wyeth (NYSE: WYE), Genentech (NYSE: DNA), Glaxo SmithKline (NYSE: GSK), Sanofi-Aventis (NYSE: SNY), Amgen (NASDAQ: AMGN), Celgene Corporation (NASDAQ: CELG), Gilead Sciences (NASDAQ: GILD), Genzyme Corp. (NASDAQ: GENZ), and Elan Corp. plc (NYSE: ELN).
JON OGG
February 5, 2009
